Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy

Abstract Objectives The aim of this study was to determine the long-term overall and disease-free survival and factors associated with overall survival in patients with esophageal cancer undergoing a totally minimally invasive Ivor Lewis esophagectomy (MILE) at a safety-net hospital. Methods This wa...

Full description

Bibliographic Details
Main Authors: Keouna Pather, Erin M. Mobley, Christina Guerrier, Rhemar Esma, Heather Kendall, Ziad T. Awad
Format: Article
Language:English
Published: BMC 2022-02-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:https://doi.org/10.1186/s12957-022-02518-0
_version_ 1818981874779815936
author Keouna Pather
Erin M. Mobley
Christina Guerrier
Rhemar Esma
Heather Kendall
Ziad T. Awad
author_facet Keouna Pather
Erin M. Mobley
Christina Guerrier
Rhemar Esma
Heather Kendall
Ziad T. Awad
author_sort Keouna Pather
collection DOAJ
description Abstract Objectives The aim of this study was to determine the long-term overall and disease-free survival and factors associated with overall survival in patients with esophageal cancer undergoing a totally minimally invasive Ivor Lewis esophagectomy (MILE) at a safety-net hospital. Methods This was a single-center retrospective review of consecutive patients who underwent MILE from September 2013 to November 2017. Overall and disease-free survival were analyzed by Kaplan-Meier estimates, and hazard ratios (HR) were derived from multivariable Cox regression models. Results Ninety-six patients underwent MILE during the study period. Overall survival at 1, 3, and 5 years was 83.2%, 61.9%, and 55.9%, respectively. Disease-free survival at 1, 3, and 5 years was 83.2%, 60.6%, and 47.5%, respectively. Overall survival (p < 0.001) and disease-free survival (p < 0.001) differed across pathological stages. By multivariable analysis, increasing age (HR, 1.06; p = 0.02), decreasing Karnofsky performance status score (HR, 0.94; p = 0.002), presence of stage IV disease (HR, 5.62; p = 0.002), locoregional recurrence (HR, 2.94; p = 0.03), and distant recurrence (HR, 4.78; p < 0.001) were negatively associated with overall survival. Overall survival significantly declined within 2 years and was independently associated with stage IV disease (HR, 3.29; p = 0.04) and distant recurrence (HR, 5.78; p < 0.001). Conclusion MILE offers favorable long-term overall and disease-free survival outcomes. Age, Karnofsky performance status score, stage IV, and disease recurrence are shown to be prognostic factors of overall survival. Prospective studies comparing long-term outcomes after different MIE approaches are warranted to validate survival outcomes after MILE.
first_indexed 2024-12-20T17:38:15Z
format Article
id doaj.art-19ed84479e9f46a7a02eb9fb43a935a3
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-20T17:38:15Z
publishDate 2022-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-19ed84479e9f46a7a02eb9fb43a935a32022-12-21T19:31:10ZengBMCWorld Journal of Surgical Oncology1477-78192022-02-0120111410.1186/s12957-022-02518-0Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomyKeouna Pather0Erin M. Mobley1Christina Guerrier2Rhemar Esma3Heather Kendall4Ziad T. Awad5Department of Surgery, University of Florida College of Medicine – JacksonvilleDepartment of Surgery, University of Florida College of Medicine – JacksonvilleDepartment of Surgery, University of Florida College of Medicine – JacksonvilleUF Health Jacksonville, JacksonvilleUF Health Jacksonville, JacksonvilleDepartment of Surgery, University of Florida College of Medicine – JacksonvilleAbstract Objectives The aim of this study was to determine the long-term overall and disease-free survival and factors associated with overall survival in patients with esophageal cancer undergoing a totally minimally invasive Ivor Lewis esophagectomy (MILE) at a safety-net hospital. Methods This was a single-center retrospective review of consecutive patients who underwent MILE from September 2013 to November 2017. Overall and disease-free survival were analyzed by Kaplan-Meier estimates, and hazard ratios (HR) were derived from multivariable Cox regression models. Results Ninety-six patients underwent MILE during the study period. Overall survival at 1, 3, and 5 years was 83.2%, 61.9%, and 55.9%, respectively. Disease-free survival at 1, 3, and 5 years was 83.2%, 60.6%, and 47.5%, respectively. Overall survival (p < 0.001) and disease-free survival (p < 0.001) differed across pathological stages. By multivariable analysis, increasing age (HR, 1.06; p = 0.02), decreasing Karnofsky performance status score (HR, 0.94; p = 0.002), presence of stage IV disease (HR, 5.62; p = 0.002), locoregional recurrence (HR, 2.94; p = 0.03), and distant recurrence (HR, 4.78; p < 0.001) were negatively associated with overall survival. Overall survival significantly declined within 2 years and was independently associated with stage IV disease (HR, 3.29; p = 0.04) and distant recurrence (HR, 5.78; p < 0.001). Conclusion MILE offers favorable long-term overall and disease-free survival outcomes. Age, Karnofsky performance status score, stage IV, and disease recurrence are shown to be prognostic factors of overall survival. Prospective studies comparing long-term outcomes after different MIE approaches are warranted to validate survival outcomes after MILE.https://doi.org/10.1186/s12957-022-02518-0Esophageal malignancyThoracic surgeryThoracolaparoscopic esophagectomyIvor Lewis esophagectomyCancer survival
spellingShingle Keouna Pather
Erin M. Mobley
Christina Guerrier
Rhemar Esma
Heather Kendall
Ziad T. Awad
Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
World Journal of Surgical Oncology
Esophageal malignancy
Thoracic surgery
Thoracolaparoscopic esophagectomy
Ivor Lewis esophagectomy
Cancer survival
title Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
title_full Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
title_fullStr Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
title_full_unstemmed Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
title_short Long-term survival outcomes of esophageal cancer after minimally invasive Ivor Lewis esophagectomy
title_sort long term survival outcomes of esophageal cancer after minimally invasive ivor lewis esophagectomy
topic Esophageal malignancy
Thoracic surgery
Thoracolaparoscopic esophagectomy
Ivor Lewis esophagectomy
Cancer survival
url https://doi.org/10.1186/s12957-022-02518-0
work_keys_str_mv AT keounapather longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy
AT erinmmobley longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy
AT christinaguerrier longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy
AT rhemaresma longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy
AT heatherkendall longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy
AT ziadtawad longtermsurvivaloutcomesofesophagealcancerafterminimallyinvasiveivorlewisesophagectomy